Acadian Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Sell
40,028
-36,321
-48% -$92.3K ﹤0.01% 1735
2026
Q1
$148K Buy
76,349
+67,123
+728% +$157K ﹤0.01% 1661
2025
Q4
$25K Sell
9,226
-1,979
-18% -$6.5K ﹤0.01% 1888
2025
Q3
$45K Buy
+11,205
New +$49.3K ﹤0.01% 1655
2022
Q3
– Sell
-10,456
Closed -$62K – 1730
2022
Q2
$62K Buy
+10,456
New +$116K ﹤0.01% 1460

Other funds holding GDRX

Acadian Asset Management's GDRX Position: Q2 2026 in Review

Acadian Asset Management reduced its GoodRx Holdings (GDRX) stake by 48% in Q2 2026, selling an estimated $92.3K and leaving 40,028 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Acadian Asset Management first reported a position in GDRX in Q2 2022 and has held it in 5 quarters since. The position peaked at $148K in Q1 2026. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Acadian Asset Management held 40,028 shares of GoodRx Holdings worth $114K as of Q2 2026.
  • Acadian Asset Management sold 36,321 GoodRx Holdings shares in Q2 2026, an estimated $92.3K.
  • GoodRx Holdings made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1735 holding.
  • Acadian Asset Management first reported a position in GoodRx Holdings in Q2 2022 and has held it in 5 quarters since.
  • Acadian Asset Management's GoodRx Holdings position peaked at $148K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.